Mao Youling – Trademark Portfolio

Entity Type: 01

Mao Youling owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LSIMT, ERIHOP, and ETOGOX. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 8 (Hand Tools) and Class 18 (Leather Goods). Headquartered in Macheng, Hubei.

No. 1 Minjiaqiao, Jianshe Road,

Macheng, Hubei 438300 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ERIHOP
ERIHOP
Registered 2020
LSIMT
LSIMT
Registered 2020
ETOGOX
ETOGOX
Registered 2020

Trademark Classifications

Mao Youling's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Mao Youling have?

Mao Youling has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Mao Youling file in?

Mao Youling files trademarks across 3 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 18 (Leather Goods), Class 16 (Paper Goods). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.

What are Mao Youling's most well-known trademarks?

Mao Youling's registered trademark portfolio includes well-known marks such as LSIMT, ERIHOP, and ETOGOX. These are among 3 currently registered trademarks in the portfolio.

What is Mao Youling's trademark registration success rate?

Mao Youling has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.